Total Payments
$811,272
2024 Payments
$16,342
Companies
34
Transactions
611
Medicare Patients
43,554
Medicare Billing
$6.5M
Payment Breakdown by Category
Research$521,343 (64.3%)
Other$214,940 (26.5%)
Consulting$30,237 (3.7%)
Travel$27,686 (3.4%)
Food & Beverage$16,804 (2.1%)
Education$261.51 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $521,343 | 28 | 64.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $214,940 | 92 | 26.5% |
| Consulting Fee | $30,237 | 16 | 3.7% |
| Travel and Lodging | $27,686 | 103 | 3.4% |
| Food and Beverage | $16,804 | 368 | 2.1% |
| Education | $261.51 | 4 | 0.0% |
Payments by Type
Research
$521,343
28 transactions
General
$289,929
583 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $368,196 | 24 | $0 (2024) |
| Lilly USA, LLC | $238,014 | 295 | $0 (2024) |
| LEO Pharma AS | $154,044 | 9 | $0 (2018) |
| GENZYME CORPORATION | $19,724 | 23 | $0 (2024) |
| ABBVIE INC. | $9,266 | 44 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $7,509 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $2,878 | 13 | $0 (2024) |
| UCB SA | $2,375 | 13 | $0 (2018) |
| Novartis Pharma AG | $1,765 | 6 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $855.11 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,342 | 70 | Lilly USA, LLC ($11,114) |
| 2023 | $74,263 | 83 | Lilly USA, LLC ($26,184) |
| 2022 | $111,420 | 38 | Eli Lilly and Company ($88,651) |
| 2021 | $196,186 | 34 | Eli Lilly and Company ($178,065) |
| 2020 | $85,401 | 35 | Eli Lilly and Company ($54,519) |
| 2019 | $61,991 | 106 | Lilly USA, LLC ($46,166) |
| 2018 | $196,133 | 127 | LEO Pharma AS ($145,908) |
| 2017 | $69,535 | 118 | Lilly USA, LLC ($57,680) |
All Payment Transactions
611 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $10.86 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: Immunology | ||||||
| 12/15/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $82.97 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $122.34 | General |
| Category: WOUND CARE | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Immunology | ||||||
| 10/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $149.53 | General |
| 10/03/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: WOUND CARE | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $122.84 | General |
| Category: Immunology | ||||||
| 09/27/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $35.78 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: DERMATOLOGY | ||||||
| 09/25/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $22.35 | General |
| Category: DERMATOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Dermatology | ||||||
| 08/28/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $21.04 | General |
| 08/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.78 | General |
| 08/12/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: Immunology | ||||||
| 08/12/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS | Eli Lilly and Company | $186,685 | 3 |
| TRALOKINUMAB MONOTHERAPY FOR MODERATE TO SEVERE ATOPIC DERMATITIS - ECZTRA 2 ECZEMA TRALOKINUMAB TRIAL NO. 2 ECZTRA 2 | LEO Pharma AS | $154,044 | 9 |
| A LONG-TERM STUDY TO ASSESS THE SAFETY AND EFFICACY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | Eli Lilly and Company | $131,038 | 4 |
| A PHASE 3, 16-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL- GROUP STUDY TO ASSESS THE IMPACT OF LEBRIKIZUMAB ON VACCINE RESPONSES IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | Eli Lilly and Company | $26,789 | 2 |
| ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3303560 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE | Eli Lilly and Company | $18,427 | 4 |
| A PHASE 3 16-WEEK RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL- GROUP STUDY TO ASSESS THE IMPACT OF LEBRIKIZUMAB ON VACCINE RESPONSES IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | Eli Lilly and Company | $1,657 | 1 |
| A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3375880 IN ADULT SUBJECTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: THE ADMIRE STUDY | Eli Lilly and Company | $1,528 | 1 |
| A MULTICENTER, LONG-TERM EXTENSION TO EVALUATE THE LONG-TERM SAFETY AND MAINTENANCE OF TREATMENT EFFECT OF LY3074828 IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS OASIS-3 | Eli Lilly and Company | $894.58 | 3 |
| A MULTICENTER STUDY WITH A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INDUCTION DOSING PERIOD FOLLOWED BY A RANDOMIZED WITHDRAWAL MAINTENANCE DOSING PERIOD TO EVALUATE THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS OASIS-1 | Eli Lilly and Company | $282.38 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 52 | 11,383 | 34,944 | $3.0M | $2.1M |
| 2022 | 49 | 10,709 | 30,324 | $2.3M | $1.5M |
| 2021 | 43 | 10,805 | 29,335 | $2.2M | $1.5M |
| 2020 | 43 | 10,657 | 27,926 | $2.1M | $1.4M |
Total Patients
43,554
Total Services
122,529
Medicare Billing
$6.5M
Procedure Codes
188
All Medicare Procedures & Services
188 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3245 | Injection, tildrakizumab, 1 mg | Office | 2023 | 20 | 4,200 | $589,198 | $461,148 | 78.3% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 353 | 442 | $333,849 | $236,909 | 71.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,324 | 2,175 | $298,301 | $207,094 | 69.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 1,247 | 1,662 | $210,918 | $144,332 | 68.4% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 238 | 356 | $163,670 | $127,736 | 78.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,752 | 2,604 | $192,245 | $98,173 | 51.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 1,554 | 16,503 | $124,129 | $96,866 | 78.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 141 | 174 | $123,065 | $85,911 | 69.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 999 | 1,260 | $121,967 | $81,756 | 67.0% |
| Q4159 | Affinity, per square centimeter | Office | 2023 | 13 | 182 | $72,419 | $56,777 | 78.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 216 | 236 | $123,707 | $49,814 | 40.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 889 | 1,410 | $55,830 | $41,700 | 74.7% |
| Q4196 | Puraply am, per square centimeter | Office | 2023 | 16 | 465 | $50,442 | $39,545 | 78.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 472 | 555 | $63,141 | $36,020 | 57.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 129 | 143 | $48,444 | $34,933 | 72.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 156 | 170 | $81,382 | $33,855 | 41.6% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 67 | 81 | $35,075 | $27,879 | 79.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 199 | 199 | $35,158 | $23,517 | 66.9% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 60 | 68 | $26,626 | $20,875 | 78.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 106 | 134 | $24,916 | $18,829 | 75.6% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 61 | 64 | $20,069 | $15,911 | 79.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 114 | 124 | $38,255 | $15,055 | 39.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 119 | 126 | $17,705 | $12,696 | 71.7% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 115 | 120 | $18,366 | $12,415 | 67.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 167 | 167 | $20,520 | $12,310 | 60.0% |
About Dr. Michael Heffernan, MD
Dr. Michael Heffernan, MD is a Dermatology healthcare provider based in San Luis Obispo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518923432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Heffernan, MD has received a total of $811,272 in payments from pharmaceutical and medical device companies, with $16,342 received in 2024. These payments were reported across 611 transactions from 34 companies. The most common payment nature is "" ($521,343).
As a Medicare-enrolled provider, Heffernan has provided services to 43,554 Medicare beneficiaries, totaling 122,529 services with total Medicare billing of $6.5M. Data is available for 4 years (2020–2023), covering 188 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Dermatology
- Location San Luis Obispo, CA
- Active Since 04/21/2006
- Last Updated 10/13/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1518923432
Products in Payments
- TALTZ (Drug) $226,295
- DUPIXENT (Biological) $20,288
- SKYRIZI (Biological) $4,741
- HUMIRA (Biological) $2,338
- LIBTAYO (Biological) $2,333
- COSENTYX (Biological) $1,233
- AIN457 (Biological) $1,176
- Humira (Biological) $669.95
- Cimzia (Drug) $524.23
- DUPIXENT (Drug) $444.43
- TREMFYA (Drug) $386.67
- Otezla (Drug) $368.19
- Tremfya (Drug) $333.28
- Sotyktu (Drug) $273.91
- CIBINQO (Drug) $249.01
- AMJEVITA (Biological) $246.17
- OLUMIANT (Drug) $224.11
- Rituxan (Biological) $204.90
- Skyrizi (Biological) $203.41
- COSENTYX (Drug) $203.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Luis Obispo
Dr. Blanca Bisuna, Md, MD
Dermatology — Payments: $13,428
Dermatology $13,428
Dr. Karen Allen, Md, MD
Dermatology — Payments: $12,777
Dermatology $12,777
Charles Fishman, M.d, M.D
Dermatology — Payments: $3,597
Dermatology $3,597
Jennifer Remington, M.d, M.D
Dermatology — Payments: $1,623
Dermatology $1,623
Dr. Shirley Van, Md, MD
Dermatology — Payments: $580.08
Dermatology $580.08
Lisa Aquino, Md, MD
Dermatology — Payments: $339.18
Dermatology $339.18